Polyclonal Rabbit anti‑Human MAPK12 / ERK6 / SAPK3 Antibody (Cy3, aa27‑311, WB) LS‑C703543
Polyclonal Rabbit anti‑Human MAPK12 / ERK6 / SAPK3 Antibody (Cy3, aa27‑311, WB) LS‑C703543
Antibody:
MAPK12 / ERK6 / SAPK3 Rabbit anti-Human Polyclonal (aa27-311) (Cy3) Antibody
Overview
Antibody:
MAPK12 / ERK6 / SAPK3 Rabbit anti-Human Polyclonal (aa27-311) (Cy3) Antibody
Specifications
Description
SAPK3 antibody LS-C703543 is a Cy3-conjugated rabbit polyclonal antibody to human SAPK3 (MAPK12 / ERK6) (aa27-311). Validated for WB.
Target
Human MAPK12 / ERK6 / SAPK3
Synonyms
MAPK12 | ERK5 | ERK6 | ERK-6 | MAP kinase 12 | MAPK 12 | MAP kinase p38 gamma | SAPK3 | p38-gamma | p38GAMMA | SAPK-3 | ERK3 | PRKM12
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Cy3.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant MAPK12 (Tyr27-Phe311)
Specificity
The antibody is a rabbit polyclonal antibody raised against MAPK12.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About MAPK12 / ERK6 / SAPK3
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, Flow Cytometry
Reactivity:
Mouse
Range:
6.25-400 pg/ml
Reactivity:
Human
Range:
0.156-10 ng/ml
Reactivity:
Human, Mouse, Rat
Range:
Positive/Negative
Reactivity:
Horse
Range:
0.156-10 µg/ml
Reactivity:
Human
Range:
3.906-250 pg/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/20/2024